期刊文献+

恶性胸膜间皮瘤治疗新进展 被引量:1

Current chemotherapy and new advances in malignant pleurai mesothelioma
原文传递
导出
摘要 恶性胸膜间皮瘤是一种胸膜恶性肿瘤,已发现其发生与石棉暴露有关。目前治疗恶性胸膜间皮瘤的方法有手术治疗、化疗和放疗,但效果均不理想。外科手术由于缺乏随机对照研究,其效果仍不确切。放疗因为恶性间皮瘤细胞的放射敏感性一般,故也存在争议。化疗对恶性胸膜间皮瘤的治疗效果相对较差。联合应用培美曲唑与顺铂能达到较好效果。多模式治疗方案被认为是目前治疗恶性胸膜间皮瘤的首选。 Malignant pleural mesothelioma (MPM) is an aggressive tumor of the pleura. The association between asbestos exposure and the development of MPM has been recognized. The current treatment of MPM includes surgery, radiotherapy, and chemotherapy, but its outcome remains unfavorable. The effects of surgery have not yet been defined because of a lack of randomized trials. The role of radiotherapy in the treatment of MPM remains controversial,as the radiosensitivity of malignant mesothelial cells is modest. The effects of chemotherapy is still relatively poor. Pemetrexed-cisplatin combination regimen has more favorable results in MPM therapy. Multimodality therapy is regarded as the best treatment of MPM at present.
作者 罗凌 吴聪
出处 《国际呼吸杂志》 2009年第12期745-748,共4页 International Journal of Respiration
关键词 恶性胸膜间皮瘤 患者 临床分析 治疗方法 Malignant pleural mesothelioma Treatment
  • 相关文献

参考文献25

  • 1Roggli VL, Sharma A, Butnor KJ, et al. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol, 2002,26: 55-65.
  • 2Gaadar AF,Carbone M. Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer, 2003,5 : 177-181.
  • 3Zellos L, Sugarbaker DJ. Current surgical management of malignant pleural mesothelioma. Curr Oncol Rep, 2002, 4: 354-360.
  • 4Tsiouris A,Gourgoulianis KI,Walesby RK. Current trends in the management of malignant pleural mesothelioma. Expert Rev Anticancer Ther, 2006,6 : 831-833.
  • 5Goerres GW, yon Schulthess GK, Steinert HC. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nuel Med,2004,45 Suppl 1 : 66S-71S.
  • 6Aziz T,Jilaihawi A,Prakash D. The management of malignant pleural mesothelioma: single centre experience in 10 years. Eur J Cardiothorac Surg, 2002,22 : 298-305.
  • 7Sugarbaker DJ, Flores RM, Jaklitseh MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg, 1999,117 : 54-63.
  • 8Richards WG,Zellos L, Bueno R,et al. Phase Ⅰ to Ⅱ study of pleurectomy/decortieation and intraoperative intracavitary hyperthermie cisplatin lavage for mesothelioma. J Clin Oncol, 2006,24: 1561-1567.
  • 9Bydder S,Phillips M,Joseph DJ, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer, 2004,91 : 9-10.
  • 10Batirel HF, Metintas M, Caglar HB, et al. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol, 2008,3 : 499-504.

同被引文献31

  • 1Nowak AK, Armato SG III, Ceresoli GL, et al. Imaging in pleural mesothelioma: a review of imaging research presented at the 9th Inter- national Meeting of the International Mesothelioma Interest Group [ J]. Lung Cancer,2010,70( 1 ) : 1 - 6.
  • 2Nowak AK, Francis RJ, Phillips MJ, et al. A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET ima- ging with clinical parameters [ J ]. Clin Cancer Res, 2010,16 ( 8 ) : 2409- 2417.
  • 3Yildirim H, Metintas M, Entok E, et al. Clinical value of fluorode- oxyglucose-positron emission tomography/computed tomography in dif- ferentiation of malignant mesothelioma from asbestos-related benign pleural disease : an observational pilot study [ J ]. J Thorac Oncol, 2009,4(12) :1480 - 1484.
  • 4Hassan R,Alexander R. Nonpleural mesotheliomas : mesothelioma of the peritoneum, tuniea vaginalis, and pericardium[ J]. Hematol On- col Clin North Am, 2005,19 ( 6 ) : 1067 - 1087.
  • 5Roggli VL, Sharma A, Butnor K J, et al. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases[J]. Uhrastruct Pathol,2002,26(2) :55 -65.
  • 6Robinson BW, Lake RA. Advances in malignant mesothelioma[J]. N Engl J Med,2005,353 ( 15 ) : 1591 - 1603.
  • 7Antman KH. Natural history and epidemiology of malignant mesothe- lioma [ J ]. Chest, 1993,103 (4 Suppl) : 373 S - 376 S.
  • 8Peto J, Decarli A, La Vecchia C, et al. The European mesothelioma epidemic [ J ]. Br J Cancer, 1999,79 ( 3 - 4) :666 - 672.
  • 9Gazdar AF, Carbone M. Molecular pathogenesis of malignant meso- thelioma and its relationship to simian virus 40[J]. Clin Lung Canc- er, 2003,5(3) :177 -181.
  • 10Pisani RJ, Colby TV, Williams DE. Malignant mesothelioma of the pleura[ J]. Mayo Clin Proc, 1988,63 (12) : 1234 - 1244.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部